Literature DB >> 3519658

Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis.

S B March, S Ratnam.   

Abstract

Escherichia coli serotype O157:H7 is a recently recognized human pathogen associated with hemorrhagic colitis. Unlike most E. coli strains, E. coli O157:H7 does not ferment sorbitol. Therefore, the efficacy of MacConkey agar containing sorbitol (SMAC medium) instead of lactose as a differential medium for the detection of E. coli O157:H7 in stool cultures was determined in comparison with MacConkey agar. The relative frequency of non-sorbitol-fermenting (NSF) organisms other than E. coli O157:H7 in feces was low at 10 to 20% (95% confidence limits), and NSF organisms also occurred mostly in small numbers. In a field trial involving over 1,000 diarrheal stools, E. coli O157:H7 was isolated from 18 stools, all of which were from patients with bloody diarrhea. In every instance, the growth of E. coli O157:H7 on SMAC medium was heavy and occurred in almost pure culture as colorless NSF colonies in contrast to fecal flora, which are mostly sorbitol fermenting and hence appear pink on this medium, whereas on MacConkey agar cultures, the growth of E. coli O157:H7 was indistinguishable from fecal flora. SMAC medium permitted ready recognition of E. coli O157:H7 in stool cultures. Detection of E. coli O157:H7 on SMAC medium had a sensitivity of 100%, a specificity of 85%, and an accuracy of 86%. SMAC medium stool culture is a simple, inexpensive, rapid, and reliable means of detecting E. coli O157:H7, and we recommend routine use of SMAC medium especially for culturing bloody stools.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519658      PMCID: PMC268739          DOI: 10.1128/jcm.23.5.869-872.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Media for the isolation and differentiation of pathogenic Esch. coli (serotypes O 111 and O 55).

Authors:  F RAPPAPORT; E HENIG
Journal:  J Clin Pathol       Date:  1952-11       Impact factor: 3.411

2.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7.

Authors:  R S Remis; K L MacDonald; L W Riley; N D Puhr; J G Wells; B R Davis; P A Blake; M L Cohen
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

3.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

4.  Sporadic occurrence of hemorrhagic colitis associated with Escherichia coli O157:H7 in Newfoundland.

Authors:  S Ratnam; S B March
Journal:  CMAJ       Date:  1986-01-01       Impact factor: 8.262

5.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

6.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

7.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

8.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

  8 in total
  131 in total

Review 1.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.

Authors:  H Karch; M Bielaszewska
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Determination of the sensitivity of a rapid Escherichia coli O157:H7 assay for testing 375-gram composite samples.

Authors:  W L Tsai; C E Miller; E R Richter
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

3.  An immunodiagnostic method for the detection of Shiga-like toxigenic Escherichia coli in faeces.

Authors:  N J Asha; D M Gascoyne-Binzi; P M Hawkey
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

4.  Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome.

Authors:  David A Sass; Kapil B Chopra; Miguel D Regueiro
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

5.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

6.  ACP Broadsheet 124: May 1990. Examination of faeces for bacterial pathogens.

Authors:  S J Pedler; K E Orr
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

7.  Evaluation of commercial latex slide test for identifying Escherichia coli O157.

Authors:  P A Chapman
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

8.  Isolation of verocytotoxin-producing Escherichia coli from milk filters in south-western Ontario.

Authors:  R C Clarke; S A McEwen; V P Gannon; H Lior; C L Gyles
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Epidemiology of bacterial pathogens associated with infectious diarrhea in Djibouti.

Authors:  I A Mikhail; E Fox; R L Haberberger; M H Ahmed; E A Abbatte
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.